90 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Supernus Competitors or Alternatives

Supernus's top competitors include Merz, Sunovion and Upsher-Smith.

Unlock 29 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Supernus's company profile

Jack A. Khattar

President & CEO

92/100
580
$897M
$661.8M
  • $897M
    $661.8M
  • 580
    $897M
  • $661.8M
  • 92/100
  • 580
  • $897M
  • $661.8M
View ProfileView
1
Supernus's Competitor - Merz logo

Philip Burchard

CEO

92/100
1,000 - 5,000
- -
$1B - 5B
  • - -
    $1B - 5B
  • 1,000 - 5,000
    - -
  • $1B - 5B
  • 92/100
  • 1,000 - 5,000
  • - -
  • $1B - 5B
View ProfileView
2
Supernus's Competitor - Sunovion logo

Antony Loebel

President & CEO

86/100
500 - 1,000
- -
$500M - 1B
  • - -
    $500M - 1B
  • 500 - 1,000
    - -
  • $500M - 1B
  • 86/100
  • 500 - 1,000
  • - -
  • $500M - 1B
View ProfileView
3
Supernus's Competitor - Upsher-Smith logo

Taku Nakaoka

Chairman & CEO

84/100
500 - 1,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 500 - 1,000
    - -
  • $100M - 500M
  • 84/100
  • 500 - 1,000
  • - -
  • $100M - 500M
View ProfileView
4
Supernus's Competitor - Galecto logo

Hans T Schambye

President & CEO

90/100
5
$324.4M
  • $324.4M
  • 5
    $324.4M
  • 90/100
  • 5
  • $324.4M
View ProfileView
5
Supernus's Competitor - Marinus logo

Scott Braunstein

Chairman & CEO

89/100
110
$231.8M
$31.5M
  • $231.8M
    $31.5M
  • 110
    $231.8M
  • $31.5M
  • 89/100
  • 110
  • $231.8M
  • $31.5M
View ProfileView
Supernus' top 32 competitors are Merz, Sunovion, Upsher-Smith, Orexigen Therapeutics, Inc., Galecto, Marinus, VIVUS, Arena, Saol Therapeutics, BrainStorm, AbbVie, NeuroNascent, Semma Therapeutics, Piramal Critical Care, Gilead, Biogen, Eisai, Aprecia, Galectin, Jazz Pharmaceuticals, Mylan, ASCEND Therapeutics, SK Biopharmaceuticals, TEVA, Bristol-Myers Squibb, Pliant, Takeda Pharmaceutical, Ambrx, FibroGen, Liminal BioSciences, rEVO Biologics and Galapagos. Together they have raised over 72.6B between their estimated 255.9K employees. Supernus has 580 employees and is ranked 13th among it's top 10 competitors. The top 10 competitors average 7,771.

Supernus VS Merz

Merz is Supernus's top competitor. Merz was founded in 1908 in Frankfurt, Hesse. Merz competes in the Pharmaceuticals field. Merz generates $938.2M more revenue than Supernus.

Supernus VS Sunovion

Sunovion is perceived as one of Supernus's biggest rivals. Sunovion's headquarters is in Marlborough, Massachusetts, and was founded in 2010. Like Supernus, Sunovion also competes in the Pharmaceuticals industry. Sunovion generates 90% of Supernus's revenue.

Supernus VS Upsher-Smith

Upsher-Smith is one of Supernus's top competitors. Upsher-Smith is a Private company that was founded in Maple Grove, Minnesota in 1919. Like Supernus, Upsher-Smith also competes in the Pharmaceuticals field. Upsher-Smith has 80 fewer employees vs. Supernus.

Looking for similar companies to Supernus?

Similar Companies

Companies in Rockville with revenue in $500M-1.0B range

See 11 companies 
Pharmaceuticals companies in Rockville

See 36 companies 
Companies in Rockville with employees in 500-1.0K range

See 55 companies 
Companies in Maryland with revenue in $500M-1.0B range

See 65 companies 
Pharmaceuticals companies with revenue in $500M-1.0B range

See 95 companies 
Pharmaceuticals & Biotechnology companies in Rockville

See 113 companies 
Companies in Washington Metropolitan Area with revenue in $500M-1.0B range

See 123 companies 
Pharmaceuticals & Biotechnology companies with revenue in $500M-1.0B range

See 159 companies 
Pharmaceuticals companies in Maryland

See 177 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Supernus and Supernus's Competitors

March 31, 2025Marketscreener
Galectin Therapeutics Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was US...
March 31, 2025Seeking Alpha
March 31, 2025Marketscreener
Conference call and webcast at 8:30 a.m. Eastern Time today NEW YORK , March 31, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI),...
April 1, 2025Owler
Galectin’s employee count had no change from 14 to Feb 2024....
March 31, 2025Seeking Alpha
April 1, 2025Owler
BrainStorm’s employee count changed from 29 in Dec 2023 to 27 in Dec 2024 decreasing 6.9% in this time period....
March 31, 2025PR Newswire
/PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2025 financial results on Friday, April 25, 2025, before the market opens. AbbVie w...
March 31, 2025PR Newswire
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, t...

Frequently Asked Questions about Supernus

  1. Who are Supernus's top competitors?

    Supernus's top 3 competitors are Merz, Sunovion, Upsher-Smith.

  2. Who is similar to Supernus?

    Merz is the most similar to Supernus. Sunovion and Upsher-Smith are also similar to Supernus.

  1. Are Supernus and Merz competitors?

    Yes, Merz is one of Supernus’s top competitors.